Teprotumumab for Thyroid-Associated Ophthalmopathy.

Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS

Open source

DOI: 10.1056/nejmoa1614949
Published: 2017 May 4
Container: The New England journal of medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1614949,
  title = {Teprotumumab for Thyroid-Associated Ophthalmopathy.},
  author = {Smith TJ and Kahaly GJ and Ezra DG and Fleming JC and Dailey RA and Tang RA and Harris GJ and Antonelli A and Salvi M and Goldberg RA and Gigantelli JW and Couch SM and Shriver EM and Hayek BR and Hink EM and Woodward RM and Gabriel K and Magni G and Douglas RS},
  year = {2017},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa1614949},
  url = {https://doi.org/10.1056/nejmoa1614949}
}

RIS

TY  - JOUR
TI  - Teprotumumab for Thyroid-Associated Ophthalmopathy.
AU  - Smith TJ
AU  - Kahaly GJ
AU  - Ezra DG
AU  - Fleming JC
AU  - Dailey RA
AU  - Tang RA
AU  - Harris GJ
AU  - Antonelli A
AU  - Salvi M
AU  - Goldberg RA
AU  - Gigantelli JW
AU  - Couch SM
AU  - Shriver EM
AU  - Hayek BR
AU  - Hink EM
AU  - Woodward RM
AU  - Gabriel K
AU  - Magni G
AU  - Douglas RS
PY  - 2017
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa1614949
UR  - https://doi.org/10.1056/nejmoa1614949
ER  -

APA

TJ, S., GJ, K., DG, E., JC, F., RA, D., RA, T., GJ, H., A, A., M, S., RA, G., JW, G., SM, C., EM, S., BR, H., EM, H., RM, W., K, G., G, M., & RS, D. (2017). Teprotumumab for Thyroid-Associated Ophthalmopathy.. The New England journal of medicine. https://doi.org/10.1056/nejmoa1614949

Source records

pubmed · retrieved 2026-09-26T17:29:52.733Z